5 things to know about the new Alzheimer’s drug — including why it may be risky for people who take blood thinners
November 30, 2022 at 11:38 AM EST
Results of clinical trial point to a stable future for Eisai and Biogen's lecanemab once the therapy is approved by the Food and Drug Administration.
